Stocks / ICUI vs OGN
ICUI vs OGN
ICU Medical, Inc. and Organon & Co. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ICU Medical, Inc. (ICUI) | Organon & Co. (OGN) | |
|---|---|---|
| Market cap | $3.5B | $3.5B |
| Revenue (latest FY) | $2.21B | $6.22B |
| Net income (latest FY) | $732,000 | $187.00M |
| Revenue growth (5y CAGR) | 11.7% | -1.0% |
| Net margin | 0.0% | 3.0% |
| Return on equity | 0.0% | 24.9% |
| P/E ratio | 75.8 | 14.4 |
| Dividend yield | — | 0.6% |
| Profitable years (of last 10) | 7 | 7 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ICUI — free Open OGN — freeFrequently asked questions
Which is bigger, ICUI or OGN?
ICU Medical, Inc. is larger by market capitalization — $3.5B versus $3.5B.
Which grows faster, ICUI or OGN?
Over the last five fiscal years, ICU Medical, Inc. grew revenue faster — 11.7%/yr versus -1.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.